|Bid||53.57 x 1300|
|Ask||53.58 x 900|
|Day's range||52.74 - 53.82|
|52-week range||42.53 - 57.05|
|Beta (5Y monthly)||0.52|
|PE ratio (TTM)||32.93|
|Earnings date||28 Jul 2022|
|Forward dividend & yield||3.60 (6.91%)|
|Ex-dividend date||14 Jun 2022|
|1y target est||57.04|
Dividend stocks can be a great place to start looking. A couple of Dividend Kings that have been doing particularly well this year are AbbVie (NYSE: ABBV) and Altria Group (NYSE: MO). AbbVie is a top healthcare stock that yields 3.7% annually, which is more than double the S&P 500 average of less than 1.4%.
In periods of rising inflation and slowing economic growth, investors often turn to the stability and reliability of dividend stocks to see them through the tough times -- and with good reason. The asset managers at Hartford Funds studied the performance of the benchmark S&P 500 going all the way back to 1930, looking at stocks that pay dividends and those that don't, and found over that near-100-year period, dividend-paying stocks contributed 41% to the index's total return. It also includes the so-called "lost decade" of the 2000s, where the dot-com bubble, 9/11, and the financial markets collapse all conspired to generate negative returns for the S&P 500, but dividend stocks still gained 1.8%.
Tobacco giant Philip Morris International (NYSE: PM) is making a splash with a blockbuster deal earlier this month to acquire Swedish Match (OTC: SWMAF) for $16 billion in an all-cash arrangement. Swedish Match is a fellow nicotine-products company, most famous for its Zyn nicotine pouches, a smokeless nicotine product. Philip Morris has a market cap of $160 billion, so this deal is pretty significant and could have some short- and long-term ramifications for shareholders.